A recent small-scale study of 11 CLL samples showed generally impaired CLL signaling responses to BCR stimulation compared to healthy B cells, and an association was noted between signaling ability and outcome [42]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.